[Pharmacovigilance of antihypertensive drugs (author's transl)].
D018663:Adrenergic Agents / Q000009:adverse effects; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D014665:Vasodilator Agents / Q000009:adverse effects
D018663:Adrenergic Agents; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D014665:Vasodilator Agents
Pharmacovigilance des médicaments de l'hypertension artérielle.